Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virus.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 20367227.
- Also identified by DOI 10.1086/651604.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report on 2 critically ill patients with pneumonitis and acute respiratory distress syndrome due to pandemic (H1N1) 2009 influenza A virus who were treated with intravenous zanamivir and had favorable clinical outcomes. Zanamivir given intravenously may be a therapeutic option in patients with critical illness and mechanical ventilation.
Medical subject headings
- Antiviral Agents
- Influenza A Virus, H1N1 Subtype
- Influenza, Human
- Pneumonia
- Zanamivir